Abstract:Background:The majority of patients with colorectal cancer (CRC) have increased levels of soluble cancer-associated biomarkers at diagnosis of primary disease.Subjects with clean colorectum at colonoscopy may however, also have increased levels of such biomarkers.The aim of the present study was to evaluate a possible association between increased levels of soluble TIMP-1, CEA, CA19-9 and YKL-40 in subjects offered colorectal endoscopy without findings of neoplastic bowel lesions and subsequent long-term risk of developing a primary malignant disease.Methods: During 2004/05 4,509 subjects were included in a multicenter study with collection of blood samples before sigmoido-and/or colonoscopy due to symptoms of CRC.The aim was to evaluate a possible relation between certain biomarkers and subsequent findings at endoscopy.A subgroup of 1,025 subjects had findings of diverticula and was chosen as research group, because the median age was similar to the subjects diagnosed with colorectal neoplasia.The levels of TIMP-1, CEA and CA19-9 were determined in EDTA plasma at an automatic analysis platform "Architect®" at Abbotts Center of Excellence, Amsterdam and YKL-40 was determined on a validated commercially available ELISA platform (Quidell, USA) at Herlev Hospital.With cut-point 12.31.2012 the subjects, who have developed a primary malignant disease, except skin cancer, were identified and a relation between the biomarker levels at endoscopy and long-term risk of developing malignancy was calculated.On the basis of calculated normal levels, the relation with the biomarkers was separated into three groups: 0 = none of the four increased; 1 = one of the four increased; 2 = two or more of the four increased.In addition, the time from endoscopy to development of malignancy within the first five years was included; the model also includes an analysis of competing risk of dead before development of malignancy.Results: In total, 152 of the 1,025 subjects with diverticula developed a primary malignant disease within the observation period.Univariate analyses of the biomarker levels in the three predefined groups showed that TIMP-1 (p=0.0004),CEA (p=0.009) and CA19-9 (p=0.028) were significantly associated with development of malignancy.In a subsequent multivariate analysis including the three biomarkers showed that increased levels were associated with development of subsequent malignancy (p=0.0014).The cumulated risk of developing a primary malignant disease within the first five years was: group 0: 0.075 (0.055-0.099); group 1: 0.088 (0.059-0.126); group 2: 0.167 (0.120-0.221).Conclusion: Increased levels of the soluble biomarkers plasma TIMP-1, CEA and CA19-9 at endoscopy with findings of diverticula are associated with subsequent risk of developing a primary malignant disease.

M2002 A Prospective Study On Gastric Intestinal Metaplasia: Typing, Expression of p53, BCL-2 and PCNA, and Long-Term Follow-Up Outcome

Changes of Histology and Expression of Mmp-2 and Nm23-H1 in Primary and Metastatic Gastric Cancer

Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

The Clinical Significance of the CD44v6 Expression in Peripheral Blood Mononuclear Cell and Cancerous Tissue of Patients with Gastric Cancer

Role of CD97stalkand CD55 As Molecular Markers for Prognosis and Therapy of Gastric Carcinoma Patients

Prognostic Value of Circulating CD133+ Cells in Patients with Gastric Cancer

Identification Of Stem-Like Cells And Clinical Significance Of Candidate Stem Cell Markers In Gastric Cancer

Long-term Follow-Up Study on Gastric Intestinal Metaplasia Subtype and Its Relation to Expression of P53, Bcl-2 and PCNA

Prognostic value of CD133+ CD54+ CD44+ circulating tumor cells in colorectal cancer with liver metastasis

The Significance of a Group of Molecular Markers and Clinicopathological Factors in Identifying Colorectal Liver Metastasis.

CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection

872 Mir-650: A Potential Prognostic Biomarker and Therapeutic Target in Non-Metastasis Colorectal Carcinoma

Utility Of Circulating Tumor Dna In Genomic Profiling Of Colorectal Cancer With Peritoneal Metastasis.

CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients

Cancer Stem Cell Marker CD133+ Tumour Cells and Clinical Outcome in Rectal Cancer

Molecular Differences between Hepatic and Extrahepatic Metastases from Left-Sided and Right-Sided Colorectal Cancer: Potential Metastatic and Prognostic Biomarkers

Investigation of transcriptional and immunological disparities among patient groups with varied prognostic risk factors in cholangiocarcinoma

Genetic markers of survival and liver recurrence after resection of liver metastases from colorectal cancer

Identification and Validation of an Immunogenic Subtype of Gastric Cancer with Abundant Intratumoural CD103+CD8+ T Cells Conferring Favourable Prognosis.

Tumor Cell-Microenvironment Interaction Models Coupled with Clinical Validation Reveal Ccl2 and Sncg As Two Predictors of Colorectal Cancer Hepatic Metastasis

p53, DCC and thymidylate synthase as predictors of survival after resection of hepatic metastases from colorectal cancer